Claudia Tredup

Dr. Claudia Tredup

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2023 in Hepatology
Verified
Journal Article
Open access
NONuria Oliva-Vilarnau
Nuria Oliva-Vilarnau
CBChristian M. Beusch
Christian M. Beusch
PSPierre Sabatier
Pierre Sabatier
ESEirini Sakaraki
Eirini Sakaraki
ATAmelie Tjaden
Amelie Tjaden
VLVolker Lauschke
Volker Lauschke
Background & Aims: The liver has a remarkable capacity to regenerate, which is sustained by the ability of hepatocytes to act as facultative stem cells that, while normally quiescent, re-enter the cell cycle after injury. Growth factor signaling is indispensable in rodents, whereas Wnt/β-catenin is not required for effective tissue repair. However, the molecular networks that control human liver regeneration remain unclear. Methods: Organotypic 3D spheroid cultures of primary human or murine hepatocytes were used to identify the signaling network underlying cell cycle re-entry. Furthermore, we performed chemogenomic screening of a library enriched for epigenetic regulators and modulators of immune function to determine the importance of epigenomic control for human hepatocyte regeneration. Results: Our results showed that, unlike in rodents, activation of Wnt/β-catenin signaling is the major mitogenic cue for adult primary human hepatocytes. Furthermore, we identified TGFβ inhibition and inflammatory signaling via NF-κB as essential steps for the quiescent-to-regenerative switch that allows Wnt/β-catenin-induced proliferation of human cells. In contrast, growth factors, but not Wnt/β-catenin signaling, triggered hyperplasia in murine hepatocytes. High-throughput screening in a human model confirmed the relevance of NFκB and revealed the critical roles of polycomb repressive complex 2 (PRC2), as well as of the bromodomain families I, II, and IV. Conclusions: This study revealed a network of NFκB, TGFβ, and Wnt/β-catenin that controls human hepatocyte regeneration in the absence of exogenous growth factors, identified novel regulators of hepatocyte proliferation, and highlighted the potential of organotypic culture systems for chemogenomic interrogation of complex physiological processes. Export

16 March 2023 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
SASuzanne Ackloo
Suzanne Ackloo
AAAlbert A. Antolin
Albert A. Antolin
JBJose Manuel Bartolome
Jose Manuel Bartolome
HBHartmut Beck
Hartmut Beck
ABAlex Bullock
Alex Bullock
CACheryl H. Arrowsmith
Cheryl H. Arrowsmith
Target 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging ‘open’ principles to develop a pharmacological tool for every human protein.

27 September 2022 in IUCrJ
Verified
Journal Article
Open access
PDF file
Apirat ChaikuadApirat Chaikuad
Apirat Chaikuad
RZRezart Zhubi
Rezart Zhubi
CTClaudia Tredup
Claudia Tredup
SKStefan Knapp
Stefan Knapp
Tripartite motif (TRIM) proteins constitute one of the largest subfamilies of the RING-type E3 ubiquitin ligases that play a role in diverse processes from homeostasis and immune response to viral restriction. While TRIM proteins typically harbor an N-terminal RING finger, a B-box and a coiled-coil domain, a high degree of diversity lies in their C termini that contain diverse protein interaction modules, most of which, both structures and their roles in intermolecular interactions, remain unknown. Here, high-resolution crystal structures of the NHL domains of three of the four human TRIM–NHL proteins, namely TRIM2, TRIM3 and TRIM71, are presented. Comparative structural analyses revealed that, despite sharing an evolutionarily conserved six-bladed β-propeller architecture, the low sequence identities resulted in distinct properties of these interaction domains at their putative binding sites for macromolecules. Interestingly, residues lining the binding cavities represent a hotspot for genetic mutations linked to several diseases. Thus, high sequence diversity within the conserved NHL domains might be essential for differentiating binding partners among TRIM–NHL proteins.

21 March 2023 in ACS Chemical Biology
Verified
Journal Article
Open access
CTClaudia Tredup
Claudia Tredup
BNBenardina Ndreshkjana
Benardina Ndreshkjana
NSNatalie S. Schneider
Natalie S. Schneider
ATAmelie Tjaden
Amelie Tjaden
AKAurino M. Kemas
Aurino M. Kemas
SMSusanne Müller
Susanne Müller

29 November 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
CTClaudia Tredup
Claudia Tredup
SASuzanne Ackloo
Suzanne Ackloo
HBHartmut Beck
Hartmut Beck
PBPeter J. Brown
Peter J. Brown
ABAlex Bullock
Alex Bullock
SKStefan Knapp
Stefan Knapp
EUbOPEN is a public–private partnership focused on four areas: chemogenomic library collection, chemical probe discovery and technology development, compound profiling in patient-derived assays, and data and reagents collection, storage and sharing.

29 May 2026 in Human Reproduction
Verified
Journal Article
Open access
MEMadison Edwards
Madison Edwards
AAAlexandra Amaral
Alexandra Amaral
ECEve M Carter
Eve M Carter
OAOliver Arnolds
Oliver Arnolds
KVKaren Vester
Karen Vester
CTClaudia Tredup
Claudia Tredup
STUDY QUESTION: Is the hydrolase ABHD2 required for progesterone-induced Ca2+ influx via CatSper and the resulting motility responses in human sperm? SUMMARY ANSWER: Progesterone-induced Ca2+ influx via CatSper and the resulting motility responses in human sperm do not require ABHD2 activity. WHAT IS KNOWN ALREADY: Sperm motility is tightly regulated by signalling pathways that are activated as sperm ascend the female reproductive tract, including progesterone triggering Ca2+ influx via the CatSper channel and inducing hyperactivated motility needed for fertilization. This process is thought to involve ABHD2, which may hydrolyze the endogenous CatSper inhibitor 2-arachidonoylglycerol (2-AG), thereby relieving inhibition and enabling calcium entry into the flagellum. STUDY DESIGN, SIZE, DURATION: Potent small molecule inhibitors of ABHD2 activity were synthesized, characterized, and used as tools to scrutinize the role of ABHD2 in activation of CatSper and regulation of sperm motility. PARTICIPANTS/MATERIALS, SETTING, METHODS: Derivatives of published ABHD2 inhibitors were optimized for in vitro potency and cellular activity and subsequently tested in human sperm motility and Ca2+ influx assays. MAIN RESULTS AND THE ROLE OF CHANCE: Progesterone does not activate ABHD2 in vitro. In addition, inhibition of ABHD2 in human sperm has no effect on progesterone-induced Ca2+ influx through CatSper nor on basal or progesterone-induced hyperactivated motility. This demonstrates that ABHD2 activity is, in fact, not required for the non-genomic action of progesterone on human sperm. LARGE SCALE DATA: None. LIMITATIONS, REASONS FOR CAUTION: We examined the effects of inhibition of the enzymatic activity of ABHD2. We cannot exclude that ABHD2 functions as a part of a larger multiprotein complex, in which it may play a structural role independent of its hydrolase activity. WIDER IMPLICATIONS OF THE FINDINGS: This study presents conclusive evidence that ABHD2 does not bind progesterone and that its hydrolase activity is not required for progesterone activation of CatSper and resulting changes in motility of human sperm. These results highlight the need for further research to elucidate the mechanism underlying the non-genomic action of progesterone on human sperm. STUDY FUNDING/COMPETING INTEREST(s): This publication is based on research funded by the Gates Foundation, reference IDs INV-040467 and ID INV-072213. The findings and conclusions contained within are those of the authors and do not necessarily reflect the positions or policies of the Gates Foundation. LT, CB, and TS were supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—project numbers 329621271 (CRU326; CB, TS), and 404595355 (Research Training Group ‘Chemical biology of ion channels (Chembion)’; LT, TS). This work was funded by the German Federal Ministry of Education and Research (BMBF) within the framework of Contraception Research, grant numbers 01GR2501A and 01GR2502A. A.A., K.V., A.T., N.D., A.H., M.W., and R.L. are employees of Nuvisan ICB GMBH, Berlin, Germany. Nuvisan is a recipient of a Gates Foundation grant. A.A. is associate editor of Human Reproduction Open.